News & Articles
Category: Press Releases
Erroneous Genetic Sequence ID’d in Specific Cells of ALS, FTD Patients
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are devastating neurodegenerative diseases with mean survival of two to five years and six to eight years, respectively. ALS is...
Barrow Surgeon Treats Essential Tremor with Focused Ultrasound
After more than a decade of living with a neurological disorder that causes involuntary and rhythmic shaking, an Arizona man has been relieved of his symptoms thanks to...
Study: Common Gout Medication Reduces Risk of Alzheimer’s, Parkinson’s, ALS
Related Coverage A groundbreaking national study co-authored by a Barrow Neurological Institute neurologist and researcher has found a common gout medication reduced risk of Alzheimer’s disease, Parkinson’s disease,...
FDA Grants Approval of New Drug Therapy to Slow the Progression of ALS
Phoenix’s Barrow Neurological Institute Instrumental in Studies that Led to Today’s FDA Approval A leading amyotrophic lateral sclerosis (ALS) neurologist at Barrow Neurological Institute played an important role...
Vegas Shooting Survivor Continues Remarkable Recovery Five Years Later
Five years after sustaining extremely critical injuries as a result of being shot in the head during the Route 91 Harvest Festival in Las Vegas, a young Arizona...